Potent reactive oxygen species-JNK-p38 activation by sodium salicylate potentiates death of primary effusion lymphoma cells

Anticancer Research

Volumn 34, Issue 4, 2014, Pages 1865-1872

  Vaeteewoottacharn, Kulthida ^a,b   Mitchai, Manthana ^a,c   Srikoon, Pattaravadee ^a   Hattori, Shinichiro ^a   Kariya, Ryusho ^a   Matsuda, Kouki ^a   Wongkham, Sopit ^b   Okada, Seiji ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KHON KAEN UNIVERSITY   (Thailand)

^c MINISTRY OF PUBLIC HEALTH   (Thailand)

Author keywords

Apoptosis; Primary effusion lymphoma; Reactive oxygen species; Sodium salicylate

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SALICYLATE SODIUM; STRESS ACTIVATED PROTEIN KINASE; ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC50; LYMPHOMA CELL; LYMPHOMA CELL LINE; MTT ASSAY; PRIMARY EFFUSION LYMPHOMA; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; WESTERN BLOTTING; DOSE RESPONSE; DRUG EFFECT; METABOLISM; TUMOR CELL LINE;

APOPTOSIS; PRIMARY EFFUSION LYMPHOMA; REACTIVE OXYGEN SPECIES; SODIUM SALICYLATE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASES; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LYMPHOMA, PRIMARY EFFUSION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; REACTIVE OXYGEN SPECIES; SODIUM SALICYLATE;

EID: 84902297735     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Chen YB, Rahemtullah A and Hochberg E: Primary effusion lymphoma. Oncologist 12: 569-576, 2007.
2. Cesarman E, Chang Y, Moore PS, Said JW and Knowles DM: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332: 1186-1191, 1995.
3. Nador RG, Cesarman E, Chadburn A, Dawson DB, Ansari MQ, Sald J and Knowles DM: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 88: 645-656, 1996.
4. Boulanger E, Gerard L, Gabarre J, Molina JM, Rapp C, Abino JF, Cadranel J, Chevret S and Oksenhendler E: Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23: 4372-4380, 2005.
5. Amann R and Peskar BA: Anti-inflammatory effects of aspirin and sodium salicylate. Eur J Pharmacol 447: 1-9, 2002.
6. Thun MJ, Henley SJ and Patrono C: Nonsteroidal antiinflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 94: 252-266, 2002.
7. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ and Vane JR: Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90: 11693-11697, 1993.
8. Mitchell JA, Saunders M, Barnes PJ, Newton R and Belvisi MG: Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. Mol Pharmacol 51: 907-912, 1997.
9. Lee EJ, Park HG and Kang HS: Sodium salicylate induces apoptosis in HCT116 colorectal cancer cells through activation of p38MAPK. Int J Oncol 23: 503-508, 2003.
10. Kiss K, Kiss J, Rudolf E, Cervinka M and Szeberenyi J: Sodium salicylate inhibits NF-kappaB and induces apoptosis in PC12 cells. J Biochem Biophys Methods 61: 229-240, 2004.
11. Klampfer L, Cammenga J, Wisniewski HG and Nimer SD: Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines. Blood 93: 2386-2394, 1999.
12. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G and Gil J: Aspirin and salicylate induce apoptosis and activation of caspases in B-cell chronic lymphocytic leukemia cells. Blood 92: 1406-1414, 1998.
13. Braun FK, Al-Yacoub N, Plotz M, Mobs M, Sterry W and Eberle J: Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand. J Invest Dermatol 132: 429-439, 2012.
14. Schwenger P, Alpert D, Skolnik EY and Vilcek J: Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol Cell Biol 18: 78-84, 1998.
15. Chung YM, Bae YS and Lee SY: Molecular ordering of ROS production, mitochondrial changes, and caspase activation during sodium salicylate-induced apoptosis. Free Radic Biol Med 34: 434-442, 2003.
16. Renne R, Zhong W, Herndier B, McGrath M, Abbey N, Kedes D and Ganem D: Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 2: 342-346, 1996.
17. Arvanitakis L, Mesri EA, Nador RG, Said JW, Asch AS, Knowles DM and Cesarman E: Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88: 2648-2654, 1996.
18. Goto H, Kojima Y, Nagai H and Okada S: Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma. Int J Hematol 97: 624-633, 2013.
19. Katano H, Hoshino Y, Morishita Y, Nakamura T, Satoh H, Iwamoto A, Herndier B and Mori S: Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma. J Med Virol 58: 394-401, 1999.
20. Seo MS, Oh SY, Park MJ, Kim SM, Kim MY, Han SI, Park HG and Kang HS: Implication of reactive oxygen species, ERK1/2, and p38MAPK in sodium salicylate-induced heat shock protein 72 expression in C6 glioma cells. Int J Mol Med 16: 841-849, 2005.
21. Pan JS, Hong MZ and Ren JL: Reactive oxygen species: a double-edged sword in oncogenesis. World J Gastroenterol 15: 1702-1707, 2009.
22. Shen HM and Liu ZG: JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. Free Radic Biol Med 40: 928-939, 2006.
23. Murono S, Yoshizaki T, Sato H, Takeshita H, Furukawa M and Pagano JS: Aspirin inhibits tumor cell invasiveness induced by Epstein-Barr virus latent membrane protein 1 through suppression of matrix metalloproteinase-9 expression. Cancer Res 60: 2555-2561, 2000.
24. Hamoudi R, Diss TC, Oksenhendler E, Pan L, Carbone A, Ascoli V, Boshoff C, Isaacson P and Du MQ: Distinct cellular origins of primary effusion lymphoma with and without EBV infection. Leuk Res 28: 333-338, 2004.
25. Abramson SB and Weissmann G: The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum 32: 1-9, 1989.
26. Weissmann G: Aspirin. Sci Am 264: 84-90, 1991.
27. Chen X, Wan Y, Bai Q, Zhang W and Zhu H: Sodium salicylate-triggered apoptosis in HL-60 cells depends on caspase-8 activation. Int J Hematol 75: 407-411, 2002.
28. Schwenger P, Alpert D, Skolnik EY and Vilcek J: Cell-typespecific activation of c-Jun N-terminal kinase by salicylates. J Cell Physiol 179: 109-114, 1999.
29. Kopp E and Ghosh S: Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 265: 956-959, 1994.
30. Pierce JW, Read MA, Ding H, Luscinskas FW and Collins T: Salicylates inhibit I kappa B-alpha phosphorylation, endothelialleukocyte adhesion molecule expression, and neutrophil transmigration. J Immunol 156: 3961-3969, 1996.
31. Keller SA, Schattner EJ and Cesarman E: Inhibition of NFkappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542, 2000.